交易中 12-12 11:04:13 美东时间
-0.005
-0.01%
今日重点评级关注:摩根士丹利:维持Kyverna Therapeutics"超配"评级,目标价从20美元升至25美元;Maxim Group:维持Capricor Therapeutics"买入"评级,目标价从25美元升至50美元
12-05 08:35
<p> Meritage Homes, the fifth-largest public homebuilder in the U.S., commemorates its 40th anniversary in 2025, marking the delivery of its 200,000th home since 1985. Founded by Steven J. Hilton and William W. Cleverly, the company evolved from a semi-custom luxury builder to focus on affordable entry-level homes in 2016. Over its history, Meritage expanded its geographic footprint through strategic mergers, acquisitions, and greenfield develo...
12-04 13:00
Shares of homebuilders and housing-linked stocks are trading higher amid a drop...
12-04 03:34
Meritage Homes (MTH) declares $0.43/share quarterly dividend, in line with previous. Forward yield 2.62% Payable Dec. 31; for shareholders of record Dec. 17; ex-div Dec. 17. The company has now announ...
11-21 17:42
Meritage Homes Corporation (NYSE:MTH, "Meritage" or the "Company"))), the fifth-largest homebuilder in the U.S., today announced that its Board of Directors has declared a quarterly dividend of $0.43 per share. This
11-21 06:22
Governor Katie Hobbs and regional leaders celebrated the grand opening of Teravalis™, a 37,000-acre master planned community in Buckeye, Arizona. The community, developed by Howard Hughes Communities™, aims to drive economic growth and provide sustainable living options. Teravalis features 100,000 homes, 55 million sq.ft. of commercial space, and over 7,000 acres of preserved open space. The community emphasizes water conservation, green infrastr...
11-17 21:01
今日重点评级关注:瑞银:维持Syndax Pharmaceuticals"买入"评级,目标价从35美元升至38美元;HC Wainwright & Co.:维持Benitec Biopharma"买入"评级,目标价从28美元升至35美元
11-05 10:35
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
10-31 10:25
Evercore ISI Group analyst Stephen Kim maintains Meritage Homes (NYSE:MTH) with a In-Line and lowers the price target from $82 to $78.
10-31 00:56
Meritage Homes (NYSE:MTH) is looking for Q4 GAAP EPS of $1.51-$1.70 vs $1.85 analyst estimate..
10-29 04:34